Ena Respiratory Overview

  • Year Founded
  • 2014

Year Founded

  • Status
  • Private

  • Employees
  • 9

Employees

  • Latest Deal Type
  • Accelerator/​Inc

  • Latest Deal Amount
  • $2.98M

  • Investors
  • 14

Ena Respiratory General Information

Description

Developer of immunomodulators designed to prevent respiratory viral infections. The company's products allow for topical delivery to the airways in order to target the primary site and activate the innate immune system in the respiratory tract to prevent viral and bacterial dissemination to the lungs, enabling patients with pre-existing lung disease to stay safe from further critical complications.

Contact Information

Formerly Known As
Innavac
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Level 9 31 Queen Street
  • Melbourne, Victoria 3000
  • Australia
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Pharmaceuticals
Vertical(s)
Corporate Office
  • Level 9 31 Queen Street
  • Melbourne, Victoria 3000
  • Australia

Ena Respiratory Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Ena Respiratory Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Accelerator/Incubator 01-Jan-2026 $2.98M Completed Clinical Trials - General
6. Later Stage VC (Series B) 22-Oct-2025 Completed Clinical Trials - General
5. Later Stage VC 27-Jan-2025 Completed Clinical Trials - General
4. Grant 09-Jan-2023 Completed Clinical Trials - General
3. Later Stage VC 15-Jun-2021 Completed Clinical Trials - General
2. Later Stage VC (Series A) 01-Sep-2020 $8.43M $13.2M Completed Clinical Trials - General
1. Seed Round 01-May-2017 $4.75M $4.75M Completed Clinical Trials - General
To view Ena Respiratory’s complete valuation and funding history, request access »

Ena Respiratory Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series A
To view Ena Respiratory’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Ena Respiratory Patents

Ena Respiratory Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2021902855-A0 Formulation Inactive 02-Sep-2021
AU-2022338350-A1 Formulation Pending 02-Sep-2021
CA-3226951-A1 Formulation Pending 02-Sep-2021
EP-4395762-A1 Formulation Pending 02-Sep-2021
EP-4395762-A4 Formulation Pending 02-Sep-2021 A61K47/60
To view Ena Respiratory’s complete patent history, request access »

Ena Respiratory Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ena Respiratory Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds
Biointelect Accelerator/Incubator
Gates Foundation Not-For-Profit Venture Capital Minority
Flu lab Impact Investing Minority
United States Department of War Government
AustralianSuper Limited Partner Minority
You’re viewing 5 of 14 investors. Get the full list »

Ena Respiratory FAQs

  • When was Ena Respiratory founded?

    Ena Respiratory was founded in 2014.

  • Where is Ena Respiratory headquartered?

    Ena Respiratory is headquartered in Melbourne, Australia.

  • What is the size of Ena Respiratory?

    Ena Respiratory has 9 total employees.

  • What industry is Ena Respiratory in?

    Ena Respiratory’s primary industry is Drug Discovery.

  • Is Ena Respiratory a private or public company?

    Ena Respiratory is a Private company.

  • What is Ena Respiratory’s current revenue?

    The current revenue for Ena Respiratory is .

  • How much funding has Ena Respiratory raised over time?

    Ena Respiratory has raised $71.1M.

  • Who are Ena Respiratory’s investors?

    Biointelect, Gates Foundation, Flu lab, United States Department of War, and AustralianSuper are 5 of 14 investors who have invested in Ena Respiratory.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process